164 related articles for article (PubMed ID: 38429085)
1. Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England.
Smittenaar R; Quaife SL; von Wagner C; Higgins T; Hubbell E; Lee L
J Epidemiol Community Health; 2024 May; 78(6):345-353. PubMed ID: 38429085
[TBL] [Abstract][Full Text] [Related]
2. Modelled mortality benefits of multi-cancer early detection screening in England.
Sasieni P; Smittenaar R; Hubbell E; Broggio J; Neal RD; Swanton C
Br J Cancer; 2023 Jul; 129(1):72-80. PubMed ID: 37185463
[TBL] [Abstract][Full Text] [Related]
3. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.
Mytton OT; Jackson C; Steinacher A; Goodman A; Langenberg C; Griffin S; Wareham N; Woodcock J
PLoS Med; 2018 Mar; 15(3):e1002517. PubMed ID: 29509767
[TBL] [Abstract][Full Text] [Related]
4. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
5. Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling.
Lange JM; Gogebakan KC; Gulati R; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):830-837. PubMed ID: 38506751
[TBL] [Abstract][Full Text] [Related]
6. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
Schmeising-Barnes N; Waller J; Marlow LAV
Soc Sci Med; 2024 Apr; 347():116762. PubMed ID: 38520825
[TBL] [Abstract][Full Text] [Related]
7. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract][Full Text] [Related]
8. Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
Kontopantelis E; Mamas MA; Webb RT; Castro A; Rutter MK; Gale CP; Ashcroft DM; Pierce M; Abel KM; Price G; Faivre-Finn C; Van Spall HGC; Graham MM; Morciano M; Martin GP; Sutton M; Doran T
PLoS Med; 2022 Feb; 19(2):e1003904. PubMed ID: 35167587
[TBL] [Abstract][Full Text] [Related]
9. Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test.
Hubbell E; Clarke CA; Aravanis AM; Berg CD
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):460-468. PubMed ID: 33328254
[TBL] [Abstract][Full Text] [Related]
10. Socio-economic inequalities in survival from screen-detected breast cancer in South West England: population-based cohort study.
McKenzie F; Ives A; Jeffreys M
Eur J Public Health; 2012 Jun; 22(3):418-22. PubMed ID: 21891789
[TBL] [Abstract][Full Text] [Related]
11. Modelling cost-effective strategies for minimising socioeconomic inequalities in colorectal cancer screening outcomes in England.
Thomas C; Mandrik O; Whyte S
Prev Med; 2022 Sep; 162():107131. PubMed ID: 35803353
[TBL] [Abstract][Full Text] [Related]
12. An Exploratory Analysis of the Cost-Effectiveness of a Multi-cancer Early Detection Blood Test Compared with Standard of Care Screening in Ontario, Canada.
Lewis D; Wong WWL; Lipscomb J; Horton S
Pharmacoeconomics; 2024 Apr; 42(4):393-407. PubMed ID: 38150120
[TBL] [Abstract][Full Text] [Related]
13. Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England.
von Wagner C; Good A; Wright D; Rachet B; Obichere A; Bloom S; Wardle J
Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S60-3. PubMed ID: 19956165
[TBL] [Abstract][Full Text] [Related]
14. Inequalities in hip fracture incidence are greatest in the North of England: regional analysis of the effects of social deprivation on hip fracture incidence across England.
Bhimjiyani A; Neuburger J; Jones T; Ben-Shlomo Y; Gregson CL
Public Health; 2018 Sep; 162():25-31. PubMed ID: 29945041
[TBL] [Abstract][Full Text] [Related]
15. Inequalities in health? An update on the effect of social deprivation for patients with breast cancer in South East Wales.
Boyce K; White C; Hunt P; Abel N; James Z; Micic T; Gomez KF
Surgeon; 2019 Apr; 17(2):88-96. PubMed ID: 29936016
[TBL] [Abstract][Full Text] [Related]
16. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
[TBL] [Abstract][Full Text] [Related]
17. Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: a population-based analysis of vital registration data.
Bennett JE; Pearson-Stuttard J; Kontis V; Capewell S; Wolfe I; Ezzati M
Lancet Public Health; 2018 Dec; 3(12):e586-e597. PubMed ID: 30473483
[TBL] [Abstract][Full Text] [Related]
18. Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Newton JN; Briggs AD; Murray CJ; Dicker D; Foreman KJ; Wang H; Naghavi M; Forouzanfar MH; Ohno SL; Barber RM; Vos T; Stanaway JD; Schmidt JC; Hughes AJ; Fay DF; Ecob R; Gresser C; McKee M; Rutter H; Abubakar I; Ali R; Anderson HR; Banerjee A; Bennett DA; Bernabé E; Bhui KS; Biryukov SM; Bourne RR; Brayne CE; Bruce NG; Brugha TS; Burch M; Capewell S; Casey D; Chowdhury R; Coates MM; Cooper C; Critchley JA; Dargan PI; Dherani MK; Elliott P; Ezzati M; Fenton KA; Fraser MS; Fürst T; Greaves F; Green MA; Gunnell DJ; Hannigan BM; Hay RJ; Hay SI; Hemingway H; Larson HJ; Looker KJ; Lunevicius R; Lyons RA; Marcenes W; Mason-Jones AJ; Matthews FE; Moller H; Murdoch ME; Newton CR; Pearce N; Piel FB; Pope D; Rahimi K; Rodriguez A; Scarborough P; Schumacher AE; Shiue I; Smeeth L; Tedstone A; Valabhji J; Williams HC; Wolfe CD; Woolf AD; Davis AC
Lancet; 2015 Dec; 386(10010):2257-74. PubMed ID: 26382241
[TBL] [Abstract][Full Text] [Related]
19. Monitoring inequalities in the National Chlamydia Screening Programme in England: added value of ACORN, a commercial geodemographic classification tool.
Sheringham J; Sowden S; Stafford M; Simms I; Raine R
Sex Health; 2009 Mar; 6(1):57-62. PubMed ID: 19254493
[TBL] [Abstract][Full Text] [Related]
20. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Navani N; Nair A; Devaraj A; Hackshaw A; Quaife SL; Janes SM;
Lancet Public Health; 2023 Feb; 8(2):e130-e140. PubMed ID: 36709053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
